March 01, 2015 6:13 AM ET

Biotechnology

Company Overview of DUSA Pharmaceuticals Inc.

Company Overview

DUSA Pharmaceuticals, Inc., a vertically integrated dermatology company, develops and markets Levulan photodynamic therapy (PDT) and other products for common skin conditions primarily in the United States, Canada, and Korea. The company’s marketed products include Levulan Kerastick 20% Topical Solution with PDT, as well as the BLU-U brand light source for the treatment of non-hyperkeratotic actinic keratoses of the face or scalp. It also markets the BLU-U without Levulan PDT for the treatment of moderate inflammatory acne vulgaris and general dermatological conditions. The company was founded in 1991 and is headquartered in Wilmington, Massachusetts. As of December 19, 2012, DUSA Pharmaceut...

25 Upton Drive

Wilmington, MA 01887

United States

Founded in 1991

99 Employees

Phone:

978-657-7500

Fax:

978-657-9193

Key Executives for DUSA Pharmaceuticals Inc.

Chief Financial Officer, Vice President of Finance and Principal Accounting Officer
Age: 44
Vice President of Operations
Age: 59
Chief Medical Officer and Vice President of Scientific Affairs
Age: 67
Vice President and Controller
Age: 49
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Intracel Resources, LLC United States
VMT Scientific Inc. United States
CoTherix, Inc. United States
Retrotope, Inc. United States
Armune BioScience, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DUSA Pharmaceuticals Inc., please visit www.dusapharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.